Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170

NCT02582749 is registered in ClinicalTrials.gov with Ajjai Alva, MD as lead sponsor.

NCT NCT02582749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02582749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170
Lead sponsor
Ajjai Alva, MD
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2016
Completion date
September 14, 2017
Enrollment
16 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, prostate cancer, prostate neoplasms